Fundz

Skye Bioscience Announces Resignation of Chief Financial Officer John P. Sharp

PUBLIC · SKYESep 11, 2026

Position

Chief Financial Officer

Company

Skye Bioscience

John P. Sharp
San DiegoBiotechnologyHealthcare

Description

On September 8, 2026, Skye Bioscience, Inc. announced the resignation of John P. Sharp from his role as Chief Financial Officer

Who to call at Skye Bioscience, and when

A new leader at Skye Bioscience brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Skye Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Skye Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Skye Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Skye Bioscience

Location

11250 EL CAMINO REAL, SUITE 100

San Diego, California, United States

About

Skye Bioscience, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system. With a focus on obesity and ocular indications, Skye is dedicated to unlocking the pharmaceutical potential of the endocannabinoid system to treat diseases with metabolic, inflammatory, and fibrotic processes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Skye Bioscience changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Punit
Senior decision-maker at this company
••••••••@••••••••

See Punit's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Skye Bioscience's next move

Learn about Strategic plan

Skye Bioscience changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.